Topic

Articles

EVP and General Manager of Hū, April Lewis, discusses why the industry has seen a decline in trial participation and what Hū is doing to combat it.

Industry Forced to Rethink Patient Participation in Trials

Eliminating barriers to engage underrepresented populations.

Importance of Diversity in Parkinson’s Research

Randomized controlled trials establish strict inclusion and exclusion criteria in an effort to optimize the cohort of trial participants.

Real-World Evidence Studies can Enhance Diversity and Equity in Clinical Research

Recognizing pre-pandemic pain points, such as patient engagement and protocol development, could lead to post-pandemic trial success. 

Addressing the Needs of Clinical Trial Sites in a Post-COVID-19 World

Evaluating the lessons learned about trial sites from COVID-19 to form new strategies and improve patient safety for the future.

Shifting Perspectives on Site Networks to Create Positive Change

With the assistance of mobile research nursing, in-home visits provide solid alternative to trial participants, especially during COVID-19.

When Trials Stumble, Mobile Research Nursing Lends a Helping Hand

Jody Casey of Elligo Health Research gives insight into the issue of diversity in trials and what needs to be done to correct it.

COVID-19 Highlights Need for More Diversity in Trials

Practical suggestions for identifying what actionable insights have been impactful on clinical studies. 

How to Measure Your Patient-Centric Impact

The pandemic has thus far disproportionally impacted minority populations, and our ongoing failure to adequately represent all patients regardless of demographic background has never been more important to remedy than it is today, writes ACRP Workforce Innovation Officer Beth Harper. 

The Time is Now to Promote Clinical Trial Workforce Diversity

Beyond technology, awareness, and access—cultural competence is key.